2.255
price up icon0.67%   0.015
 
loading

Opus Genetics Inc Aktie (IRD) Neueste Nachrichten

pulisher
06:50 AM

Is Opus Genetics Inc. stock positioned well for digital economy2025 Earnings Impact & Daily Market Momentum Tracking - Newser

06:50 AM
pulisher
03:51 AM

Opus Genetics, Inc. (NASDAQ:IRD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

03:51 AM
pulisher
Dec 04, 2025

How Opus Genetics Inc. (R3X1) stock trades after rate cutsMarket Risk Analysis & Smart Allocation Stock Reports - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Opus Genetics Inc. (R3X1) stock gets analyst attentionOptions Play & High Accuracy Trade Signal Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Equities Analysts Offer Predictions for Opus Genetics FY2025 Earnings - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

How Opus Genetics Inc. (R3X1) stock trades under stagflationAnalyst Downgrade & Fast Entry High Yield Stock Tips - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why institutional investors increase stakes in Opus Genetics Inc. (R3X1) stockMarket Growth Summary & Verified Entry Point Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Opus Genetics Inc. (R3X1) stock outperform small cap peers2025 Market WrapUp & Growth Focused Stock Reports - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Brokers Issue Forecasts for Opus Genetics FY2025 Earnings - Defense World

Dec 04, 2025
pulisher
Dec 03, 2025

Opus Genetics (NASDAQ:IRD) Upgraded to "Strong-Buy" at Brookline Capital Management - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Why Opus Genetics Inc. stock remains on buy listsJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Brookline Capital Management Upgrades Opus Genetics (NASDAQ:IRD) to Strong-Buy - Defense World

Dec 03, 2025
pulisher
Dec 02, 2025

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Dec 02, 2025
pulisher
Dec 02, 2025

Why Opus Genetics Inc. (R3X1) stock remains stable2025 Technical Patterns & Long-Term Growth Portfolio Plans - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will Opus Genetics Inc. (R3X1) stock test record highs in 2025Weekly Profit Summary & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Brookline Capital Markets initiates Buy rating on Opus Genetics stock By Investing.com - Investing.com Canada

Dec 01, 2025
pulisher
Nov 29, 2025

Opus Genetics, Inc.'s (NASDAQ:IRD) large institutional owners must be happy as stock continues to impress, up 12% over the past week - simplywall.st

Nov 29, 2025
pulisher
Nov 29, 2025

Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT - Insider Monkey

Nov 29, 2025
pulisher
Nov 28, 2025

Opus Genetics (NASDAQ:IRD) Earns Overweight Rating from Analysts at Piper Sandler - Defense World

Nov 28, 2025
pulisher
Nov 27, 2025

12 Hot Penny Stocks to Invest in Right Now - Insider Monkey

Nov 27, 2025
pulisher
Nov 27, 2025

Opus Genetics (NASDAQ:IRD) Coverage Initiated at Piper Sandler - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Analysts’ Top Healthcare Picks: Amgen (AMGN), Opus Genetics (IRD) - The Globe and Mail

Nov 26, 2025
pulisher
Nov 25, 2025

Piper Sandler Initiates Coverage on IRD with Overweight Rating a - GuruFocus

Nov 25, 2025
pulisher
Nov 25, 2025

Opus Genetics gets 'overweight' rating as Piper Sandler initiates coverage - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Piper Sandler initiates coverage on Opus Genetics stock with Overweight rating - Investing.com Canada

Nov 25, 2025
pulisher
Nov 25, 2025

Opus Genetics, Inc. $IRD is BIOS Capital Management LP’s 2nd Largest Position - Defense World

Nov 25, 2025
pulisher
Nov 24, 2025

Opus Genetics Inc R3X1 Stock Analysis and ForecastCurrency Fluctuation Impact & Consistent High Yield Stocks - earlytimes.in

Nov 24, 2025
pulisher
Nov 22, 2025

Opus Genetics’ New Study on Vision Improvement: What Investors Need to Know - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Bristol-Myers Squibb (BMY) and PACS Group Inc (PACS) - The Globe and Mail

Nov 21, 2025
pulisher
Nov 21, 2025

How Opus Genetics Inc. (R3X1) stock reacts to fiscal policies2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Opus Genetics Inc. (R3X1) stock a safe buy pre earningsJuly 2025 Patterns & Verified Technical Signals - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What is the fair value estimate for Opus Genetics Inc. (R3X1) stock in 2025Take Profit & Risk Controlled Daily Trade Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Opus Genetics (IRD) Price Target Increased by 13.45% to 7.87 - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Opus Genetics to Participate in Upcoming Investment Conferences - The Manila Times

Nov 20, 2025
pulisher
Nov 20, 2025

Will Opus Genetics Inc. (R3X1) stock rise with strong economy2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Opus Genetics Inc. stock positioned for digital transformationJuly 2025 Volume & Daily Entry Point Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Opus Genetics Inc. stock attract ESG capital inflows2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Opus Genetics, Inc.Common Stock (NQ: IRD - Markets Financial Content

Nov 20, 2025
$39.52
price up icon 0.89%
$31.73
price down icon 0.96%
$103.04
price up icon 2.54%
$96.30
price up icon 0.27%
biotechnology ONC
$320.38
price down icon 3.39%
$204.74
price down icon 0.15%
Kapitalisierung:     |  Volumen (24h):